The purpose of this study is to assess the safety of intravenous (IV) cocaine in subjects
taking quetiapine at 3 dosage levels.
A placebo-controlled, double-blind, inpatient assessment of interaction between intravenous
cocaine and quetiapine (seroquel) in cocaine-experienced subjects. To assess the safety of
IV cocaine in subjects taking quetiapine at 3 dosage levels.
Includes but is not limited to: non-treatment seeking individuals. Must meet DSM-IV
criteria for cocaine abuse or dependence. Must be able to verbalize understanding of
consent and provide written informed consent and verbalize willingness to complete study
procedures. Site will provide further details.
Please contact site for further information